Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group Study

被引:274
|
作者
Mulhern, RK
Kepner, JL
Thomas, PR
Armstrong, FD
Friedman, HS
Kun, LE
机构
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA
[3] Univ Tennessee, Coll Med, Dept Radiat Oncol, Memphis, TN USA
[4] Univ Florida, Dept Stat, Pediat Oncol Grp, Stat Off, Gainesville, FL 32611 USA
[5] Univ Miami, Sch Med, Dept Pediat, Miami, FL USA
[6] Temple Univ, Ctr Canc, Philadelphia, PA 19122 USA
[7] Temple Univ, Dept Radiat Oncol, Philadelphia, PA 19122 USA
[8] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
关键词
D O I
10.1200/JCO.1998.16.5.1723
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to ten the hypothesis that survivors of medulloblastoma who were younger at diagnosis and those who received standard-dose cranial irradiation (SRT) of 36 Gy would have a lower performance on standardized tests of cognitive function and achievement than children who were older and those treated with reduced-dose cranial irradiation (RRT) of 23.4 Gy. Patients and Methods: Eligible patients had been treated on Pediatric Oncology Group (POG) study 8631 for law-risk medulloblastoma that randomized patients to receive RRT or SRT after surgical resection. Those who were alive and free of progressive disease 6.1 to 9.9 years from completion of treatment were eligible for this study. Of the 35 eligible patients, 22 patients (13 SRT, nine RRT) participated in a battery of tests that included intellectual and academic development as well as ratings of health-related quality of life. Results: Patients were stratified by treatment group (SRT v RRT) and into younger (Y) and older (O) groups by the median age at diagnosis (8.85 years), which resulted in four groups that we hypothesized would show neuropsychologic test scores in the following order: Y/SRT less than Y/RRT less than O/SRT less than O/RRT. Evidence to support the hypothesized ordering of groups in terms of neuropsychologic toxicity wets obtained with regard to Performance Intelligence Quotient (IQ), Full Scale IQ, Attention, Reading, and Arithmetic. Conclusion: Children heated for medulloblastoma experienced less severe neuropsychologic toxicity when heated with 23.4 Gy instead of 36 Gy cranial irradiation. Older children experienced less toxicity than children who were younger at the time of irradiation. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:1723 / 1728
页数:6
相关论文
共 50 条
  • [41] HIGH-DOSE CYTARABINE FOR INTENSIFICATION OF EARLY THERAPY OF CHILDHOOD ACUTE MYELOID-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
    RAVINDRANATH, Y
    STEUBER, CP
    KRISCHER, J
    CIVIN, CI
    DUCORE, J
    VEGA, R
    PITEL, P
    INOUE, S
    BLEHER, E
    SEXAUER, C
    HUTTER, J
    VIETTI, T
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 572 - 580
  • [42] Standardized assessment of late effects in long-term survivors of childhood cancer in Switzerland - Results of a Swiss Pediatric Oncology Group (SPOG) pilot study
    VonDerWeid, N
    Beck, D
    Caflisch, U
    Feldges, A
    Wyss, M
    Wagner, HP
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1996, 3 (06): : 483 - 490
  • [43] An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children?s Oncology Group Study ACNS0331)
    Schiff, Joshua P.
    Lee, Yimei
    Wang, Yu
    Perkins, Stephanie M.
    Kessel, Sandy K.
    Fitzgerald, Thomas J.
    Larrier, Nicole A.
    Michalski, Jeff M.
    ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (01)
  • [44] HIGH-DOSE CYCLOPHOSPHAMIDE - HIGH-DOSE METHOTREXATE WITH COORDINATED INTRATHECAL THERAPY FOR ADVANCED NONLYMPHOBLASTIC LYMPHOMA OF CHILDHOOD - RESULTS OF A PEDIATRIC ONCOLOGY GROUP-STUDY
    SULLIVAN, MP
    BRECHER, M
    RAMIREZ, I
    RAGAB, A
    HVIZDALA, E
    PULLEN, J
    SHUSTER, J
    BERARD, C
    CRIST, W
    VIETTI, T
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (03): : 288 - 295
  • [45] Results of ACNS0331: Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) in Average-Risk Medulloblastoma: A Report from Children's Oncology Group
    Michalski, J.
    Vezina, G.
    Burger, P.
    Gajjar, A.
    Pollack, I.
    Merchant, T.
    Fitzgerald, T.
    Booth, T.
    Tarbell, N.
    Shieh, I.
    Williams-Hughes, C.
    Li, Y.
    Billups, C.
    Packer, R.
    Janss, A.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S7 - S7
  • [46] PRELIMINARY RESULTS OF COG ACNS0331: A PHASE III TRIAL OF INVOLVED FIELD RADIOTHERAPY (IFRT) AND LOW DOSE CRANIOSPINAL IRRADIATION (LD-CSI) WITH CHEMOTHERAPY IN AVERAGE RISK MEDULLOBLASTOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
    Michalski, Jeff
    Vezina, Gilbert
    Burger, Peter
    Gajjar, Amar
    Pollack, Ian
    Merchant, Thomas
    Fitzgerald, T. J.
    Booth, Timothy
    Tarbell, Nancy
    Shieh, Ingrid
    Williams-Hughes, Chris
    Li, Yimei
    Billups, Catherine
    Packer, Roger
    Janss, Anna
    NEURO-ONCOLOGY, 2016, 18 : 122 - 122
  • [47] HIGH-DOSE METHOTREXATE AS PART OF REMISSION MAINTENANCE THERAPY FOR CHILDHOOD ACUTE LYMPHOCYTIC-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP PILOT-STUDY
    FRANKEL, LS
    WANG, YM
    SHUSTER, J
    NITSCHKE, R
    DOERING, EJ
    PULLEN, J
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 804 - 809
  • [48] Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: A pediatric oncology group randomized phase II study
    Steuber, CP
    Krischer, J
    Holbrook, T
    Camitta, B
    Land, V
    Sexauer, C
    Mahoney, D
    Weinstein, H
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1521 - 1525
  • [49] Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group
    Michalski, J. M.
    Janss, A.
    Vezina, G.
    Gajjar, A.
    Pollack, I.
    Merchant, T. E.
    FitzGerald, T. J.
    Booth, T.
    Tarbell, N. J.
    Li, Y.
    Billups, C. A.
    Perkins, S. M.
    Timmerman, R. D.
    Cherlow, J. M.
    Packer, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (05): : 937 - 938
  • [50] HIGH-DOSE ARABINOSYL CYTOSINE (HDA) FOR INDUCTION AND CONSOLIDATION IN CHILDHOOD ACUTE NON-LYMPHOBLASTIC LEUKEMIA (ANLL) - A PEDIATRIC ONCOLOGY GROUP (POG) STUDY
    RAVINDRANATH, Y
    KRISCHER, J
    STEUBER, P
    CIVIN, C
    DUCORE, J
    VEGA, R
    CASSANO, W
    INOUE, S
    VIETTI, T
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 408 - 409